SLV-2436 is primarily utilized in the field of neuroscience research, where it serves as a selective antagonist for specific neuroreceptors. Its application is crucial in studying the mechanisms of neuropsychiatric disorders, such as anxiety and depression. Researchers employ SLV-2436 to investigate the role of receptor modulation in brain function and behavior, aiding in the development of potential therapeutic agents. Additionally, it is used in preclinical studies to evaluate the efficacy and safety of novel compounds targeting similar pathways. Its selectivity and potency make it a valuable tool for understanding receptor interactions and their implications in neurological diseases.